Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in HYFT — MindWalk Holdings Corp.

CIK 1446194 BALA CYNWYD, PA
Back to HYFT Full portfolio

Position in HYFT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$822,815
+$219,378 QoQ
Shares Held
520,769
-2.5% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 27 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HYFT Over Time

Shares Held

Position Value (USD)

Derivatives in HYFT

reported options exposure · as of Mar 31, 2026
CallValue
$12,317
CallShares
10,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,280,390 across 349 Biotechnology names. HYFT ranks #135 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in HYFT

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $822,815 520,769
2026-03-31 $603,437 534,016
2026-03-31 $12,317 10,900
2025-12-31 $965,757 530,636
2025-12-31 $33,124 18,200
2025-09-30 $166,425 95,100
2025-09-30 $877,973 501,699